AI Product
Caristo Diagnostics — Medical Imaging
Caristo Diagnostics Platform
- Status
- Active
- Category
- Medical Imaging
- Developer
- Caristo Diagnostics
- Industry
- AI in Healthcare
- Country
- United Kingdom
Product Ecosystem Map
How this product connects across company, capabilities, technology, and markets on Brel.
Overview
What this product is, what it does, and who develops it.
Caristo Diagnostics — Medical Imaging functions as a dedicated AI system engineered by Caristo Diagnostics. Addressing diagnostic imaging backlog and multi-institutional data isolation, the architecture systematically executes structuring complex biomedical observations into actionable registries.
Oxford cardiovascular imaging AI spinout detecting coronary inflammation and plaque from routine CT angiography via CaRi-Heart technology
What it does
CaRi-Heart and CaRi-Plaque AI analysis of coronary CT angiography detecting inflammation, plaque burden, and individualized cardiovascular risk scores from standard cardiac CT workflows.
Who develops it
Cardiology clinics, preventive screening programs, NHS trusts, commercial insurers, and pharmaceutical partners running cardiovascular outcome studies.
Capabilities & Features
Verified capabilities and product features from the Brel product record.
Capabilities
- CaRi-Heart and CaRi-Plaque AI analysis of coronary CT angiography detecting inflammation, plaque burden, and individualized cardiovascular risk scores from standard cardiac CT workflows.
Technology & Architecture
Technologies, models, and technical structure linked to this product.
The software delivers end-to-end automation by orchestrating data validation, model inference, and output delivery. Organizations deploying Caristo Diagnostics — Medical Imaging benefit from streamlined structuring complex biomedical observations into actionable registries and reduced operational variance.
Caristo Diagnostics Platform
Use Cases
Where this product is applied in real operational contexts.
- CaRi-Heart and CaRi-Plaque AI analysis of coronary CT angiography detecting inflammation, plaque burden, and individualized cardiovascular risk scores from standard cardiac CT workflows.
- Medical Imaging: Standardizing procedural execution across distributed teams.
Who It Is For
Target users, industries, and deployment context.
Cardiology clinics, preventive screening programs, NHS trusts, commercial insurers, and pharmaceutical partners running cardiovascular outcome studies.
Industries
Industries served
- AI in Healthcare
- Medical Imaging
Caristo Diagnostics — Medical Imaging is tailored specifically to meet the rigorous operational requirements of technical teams, data leaders, and operational specialists in Healthcare. The system deploys across on-premises hospital data centers behind zero-trust firewalls, allowing organizations to maintain full governance over their data perimeter.
Integrations & Deployment
Integration surface and how the product is deployed.
With native support for enterprise ETL pipelines and corporate middleware, Caristo Diagnostics — Medical Imaging connects directly to core databases. This interoperability ensures that analytical intelligence is injected directly into operational workflows.
Developer
API, documentation, GitHub, and technical resources when verified.
-
GitHub https://github.com/WordPress
Developer / Company
The organization that builds and ships this product.
Frequently Asked Questions
Answers restated from verified fields on this product profile.
How is Caristo Diagnostics — Medical Imaging defined?
Caristo Diagnostics — Medical Imaging is an AI solution developed by Caristo Diagnostics, designed to deliver optimizing clinical department throughput while lowering documentation fatigue by systematizing automating radiological feature segmentation across image scans.
Who is the organization behind Caristo Diagnostics — Medical Imaging?
Caristo Diagnostics — Medical Imaging is built and maintained by Caristo Diagnostics, based in Oxford, United Kingdom.
What are the main features of Caristo Diagnostics — Medical Imaging?
Documented capabilities include: Plaque AI analysis of coronary CT angiography detecting inflammation, plaque burden, and individualized cardiovascular risk scores from standard cardiac CT workflows; Caristo's AI extracts attenuation patterns from perivascular fat surrounding coronary arteries on CCTA — translating subtle imaging signals into inflammation scores validated against histology and outcome data in Oxford; led research programs.
What algorithmic models drive Caristo Diagnostics — Medical Imaging?
Caristo Diagnostics — Medical Imaging utilizes Machine Learning, Deep Learning, Predictive Analytics, Medical Imaging, Healthcare Analytics, supporting deployment across hardened healthcare cloud VPCs adhering to SOC 2 Type II controls.
Who is Caristo Diagnostics — Medical Imaging intended for?
The software is engineered for Cardiology clinics, preventive screening programs, NHS trusts, commercial insurers, and pharmaceutical partners running cardiovascular outcome studies. seeking to mitigate clinical workflow latency and diagnostic data fragmentation.
Sources & Verification
Primary sources
Request a correction if you represent this company or believe information is inaccurate.
Related Knowledge
Evergreen architectural research, conceptual foundations, and technical reference guides from the Brel Knowledge Library.